David Mazzo

David Mazzo

Chief Executive Officer chez LISATA THERAPEUTICS, INC.

Fortune : 545 270 $ au 31/03/2024

67 ans
Health Technology
Consumer Services
Finance

Profil

David J.
Mazzo
is currently the President, Chief Executive Officer & Director at Lisata Therapeutics, Inc. and the Chairman at Feldan Bio, Inc. He is also a Member of the American Association of Pharmaceutical Scientists, a Member of AOAC International, and a Trustee at Bonnie Brae, Inc. In the past, Dr. Mazzo held positions such as President, CEO & Executive Director at Æterna Zentaris, Inc., Chief Executive Officer & Executive Director at Regado Biosciences, Inc., Chief Executive Officer & Director at Caladrius Biosciences, Inc., President, CEO & Executive Director at Chugai Pharma USA LLC, and Chief Executive Officer at Essex Chimie AG.
He also served as Chairman at Visioneering Technologies, Inc. from 2020 to 2024 and as an Independent Director at Avanir Pharmaceuticals, Inc. from 2005 to 2015.
Additionally, he was a Senior Director at Rhone-Poulenc Rorer, Inc. from 1991 to 1997 and an Independent Non-Executive Director at EyePoint Pharmaceuticals, Inc. from 2005 to 2020.
He served as an Independent Director at Seneca Biopharma, Inc. from 2019 to 2021.
Dr. Mazzo's education includes a graduate and doctorate degree from the University of Massachusetts and an undergraduate degree from Villanova University, which he received in 1979.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
11/01/2024 174 766 ( 2,10% ) 545 270 $ 31/03/2024

Postes actifs de David Mazzo

SociétésPosteDébut
LISATA THERAPEUTICS, INC. Chief Executive Officer 15/09/2022
Chairman 01/10/2023
Bonnie Brae, Inc. Director/Board Member 30/12/2010
AOAC International Corporate Officer/Principal -
Corporate Officer/Principal -
Tous les postes actifs de David Mazzo

Anciens postes connus de David Mazzo

SociétésPosteFin
VISIONEERING TECHNOLOGIES, INC. Chairman 29/02/2024
PALISADE BIO, INC. Director/Board Member 27/04/2021
EYEPOINT PHARMACEUTICALS, INC. Chairman 10/09/2018
AVANIR PHARMACEUTICALS INC Director/Board Member 13/01/2015
░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de David Mazzo

Formation de David Mazzo

University of Massachusetts Doctorate Degree
Villanova University Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de David Mazzo

Relations

100 +

Relations au 1er degré

23

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées4
AETERNA ZENTARIS INC.

Health Technology

EYEPOINT PHARMACEUTICALS, INC.

Health Technology

VISIONEERING TECHNOLOGIES, INC.

Electronic Technology

LISATA THERAPEUTICS, INC.

Health Technology

Entreprise privées17

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

AOAC International

Hoechst Marion Roussel, Inc.

Bonnie Brae, Inc.

Process Industries

Health Technology

Essex Chimie AG

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. David Mazzo